Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | TILS related to BRCA-like status

Marleen Kok • 12 May 2020
ESMO Breast 2020
Breast Cancer

Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam, The Netherlands, outlines tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomized to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Marleen Kok

1:08
St Gallen 2023: de-escalation, personalized treatment & adjuvant IO following neoadjuvant IO
Marleen Kok • 16 Mar 2023
0:58
Personalizing approaches in early-stage TNBC
Marleen Kok • 16 Mar 2023
3:17
Multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer
Marleen Kok • 16 Mar 2023
1:34
Strategies to improve the response to immunotherapy in TNBC
Marleen Kok • 16 Mar 2023

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals